We are thrilled about WuXi NextCODE’s contribution of its artificial intelligence (AI) and sequencing teams to the discovery of a novel mechanism regulating how blood vessels grow. The study, ‘FGF-dependent metabolic control of vascular development,’ led by Yale University’s Michael Simons and including scientists from six countries, is published in the latest edition of Nature.

AI enables us to derive even more value from our genomics platform by mapping the complex underlying biology of disease. This work is an excellent example of yet another application of this technology to advance knowledge and potentially point the way to new drugs to treat some of our biggest health challenges.